Discovery of Widespread Transcription Initiation at Microsatellites
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
In Silico Prediction of High-Resolution Hi-C Interaction Matrices
ARTICLE https://doi.org/10.1038/s41467-019-13423-8 OPEN In silico prediction of high-resolution Hi-C interaction matrices Shilu Zhang1, Deborah Chasman 1, Sara Knaack1 & Sushmita Roy1,2* The three-dimensional (3D) organization of the genome plays an important role in gene regulation bringing distal sequence elements in 3D proximity to genes hundreds of kilobases away. Hi-C is a powerful genome-wide technique to study 3D genome organization. Owing to 1234567890():,; experimental costs, high resolution Hi-C datasets are limited to a few cell lines. Computa- tional prediction of Hi-C counts can offer a scalable and inexpensive approach to examine 3D genome organization across multiple cellular contexts. Here we present HiC-Reg, an approach to predict contact counts from one-dimensional regulatory signals. HiC-Reg pre- dictions identify topologically associating domains and significant interactions that are enri- ched for CCCTC-binding factor (CTCF) bidirectional motifs and interactions identified from complementary sources. CTCF and chromatin marks, especially repressive and elongation marks, are most important for HiC-Reg’s predictive performance. Taken together, HiC-Reg provides a powerful framework to generate high-resolution profiles of contact counts that can be used to study individual locus level interactions and higher-order organizational units of the genome. 1 Wisconsin Institute for Discovery, 330 North Orchard Street, Madison, WI 53715, USA. 2 Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI 53715, USA. *email: [email protected] NATURE COMMUNICATIONS | (2019) 10:5449 | https://doi.org/10.1038/s41467-019-13423-8 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13423-8 he three-dimensional (3D) organization of the genome has Results Temerged as an important component of the gene regulation HiC-Reg for predicting contact count using Random Forests. -
NPRL3 Gene NPR3 Like, GATOR1 Complex Subunit
NPRL3 gene NPR3 like, GATOR1 complex subunit Normal Function The NPRL3 gene provides instructions for making a protein that is one piece of a group of proteins (complex) called GATOR1. This complex is found in cells throughout the body, where it regulates a signaling pathway called the mTOR pathway. The mTOR pathway is involved in cell growth and division (proliferation), the survival of cells, and the creation (synthesis) of new proteins. The role of the GATOR1 complex is to block this pathway by inhibiting (stopping) the activity of a complex called mTOR complex 1 ( mTORC1) that is integral to the mTOR pathway. In the brain, the mTOR pathway regulates many processes, including the growth and development of nerve cells and their ability to change and adapt over time (plasticity). Health Conditions Related to Genetic Changes Familial focal epilepsy with variable foci At least ten NPRL3 gene mutations have been found to cause familial focal epilepsy with variable foci (FFEVF), which is an uncommon form of recurrent seizures (epilepsy) that runs in families. Most of these mutations lead to the production of an abnormally short, nonfunctional protein. As a result, formation of normal GATOR1 complex is reduced, leading to overactivity of mTORC1 and excessive signaling of the mTOR pathway. It is not clear how an abnormally active mTOR pathway leads to the seizures of FFEVF. Research suggests that increased mTOR pathway signaling in the brain leads to changes in the connections between nerve cells (synapses) and increased activation (excitation) -
Repetitive Elements in Humans
International Journal of Molecular Sciences Review Repetitive Elements in Humans Thomas Liehr Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University, Am Klinikum 1, D-07747 Jena, Germany; [email protected] Abstract: Repetitive DNA in humans is still widely considered to be meaningless, and variations within this part of the genome are generally considered to be harmless to the carrier. In contrast, for euchromatic variation, one becomes more careful in classifying inter-individual differences as meaningless and rather tends to see them as possible influencers of the so-called ‘genetic background’, being able to at least potentially influence disease susceptibilities. Here, the known ‘bad boys’ among repetitive DNAs are reviewed. Variable numbers of tandem repeats (VNTRs = micro- and minisatellites), small-scale repetitive elements (SSREs) and even chromosomal heteromorphisms (CHs) may therefore have direct or indirect influences on human diseases and susceptibilities. Summarizing this specific aspect here for the first time should contribute to stimulating more research on human repetitive DNA. It should also become clear that these kinds of studies must be done at all available levels of resolution, i.e., from the base pair to chromosomal level and, importantly, the epigenetic level, as well. Keywords: variable numbers of tandem repeats (VNTRs); microsatellites; minisatellites; small-scale repetitive elements (SSREs); chromosomal heteromorphisms (CHs); higher-order repeat (HOR); retroviral DNA 1. Introduction Citation: Liehr, T. Repetitive In humans, like in other higher species, the genome of one individual never looks 100% Elements in Humans. Int. J. Mol. Sci. alike to another one [1], even among those of the same gender or between monozygotic 2021, 22, 2072. -
Torture in Healthcare Settings: Reflections on the Special Rapporteur on Torture’S 2013 Thematic Report TORTURE in HEALTHCARE SETTINGS
Torture in Healthcare Settings: Reflections on the Special Rapporteur on Torture’s 2013 Thematic Report TORTURE IN HEALTHCARE SETTINGS: IN HEALTHCARE TORTURE Reflections on the Special Rapporteur on Torture’s 2013 Thematic Report Torture’s Reflections on the Special Rapporteur CENTER FOR HUMAN RIGHTS & HUMANITARIAN LAW Anti-Torture Initiative Torture in Healthcare Settings: Reflections on the Special Rapporteur on Torture’s 2013 Thematic Report CENTER FOR HUMAN RIGHTS & HUMANITARIAN LAW Anti-Torture Initiative ii TORTURE IN HEALTHCARE SETTINGS: Reflections on the Special Rapporteur on Torture’s 2013 Thematic Report Table of Contents vii Acknowledgments ix About the Center for Human Rights & Humanitarian Law and the Anti-Torture Initiative xi About the Mandate of the UN Special Rapporteur on Torture xiii Foreword: Hadar Harris xv Introduction: Juan E. Méndez 1 I. The Prohibition of Torture and the Right to Health: An Overview 3 A Contribution by the Special Rapporteur on the Right to Health: Right to Health and Freedom from Torture and Ill-Treatment in Health Care Settings Anand Grover & Jamshid Gaziyev 19 The Problem of Torture in Health Care Tamar Ezer, Jonathan Cohen, Ryan Quinn 43 The U.N. Committee Against Torture and the Eradication of Torture in Health Care Settings Claudio Grossman 49 II. Abusive Practices in Health Care Settings and International Human Rights Law: Reflections 51 Torture or Ill-Treatment in Reproductive Health Care: A Form of Gender Discrimination Luisa Cabal & Amanda McRae 65 Poor Access to Comprehensive Prenatal -
Genomic Diagnostics Within a Medically Underserved Population: Efficacy and Implications
© American College of Medical Genetics and Genomics ORIGINAL RESEARCH ARTICLE Genomic diagnostics within a medically underserved population: efficacy and implications Kevin A. Strauss, MD1, Claudia Gonzaga-Jauregui, PhD2, Karlla W. Brigatti, MS1, Katie B. Williams, MD, PhD1, Alejandra K. King, PhD2, Cristopher Van Hout, PhD2, Donna L. Robinson, CRNP1, Millie Young, RNC1, Kavita Praveen, PhD2, Adam D. Heaps, MS1, Mindy Kuebler, MS1, Aris Baras, MD2, Jeffrey G. Reid, PhD2, John D. Overton, PhD2, Frederick E. Dewey, MD2, Robert N. Jinks, PhD3, Ian Finnegan, BA3, Scott J. Mellis, MD, PhD2, Alan R. Shuldiner, MD2 and Erik G. Puffenberger, PhD1 Purpose: We integrated whole-exome sequencing (WES) and Compared to trio analysis, “family” WES (average seven exomes chromosomal microarray analysis (CMA) into a clinical workflow per proband) reduced filtered candidate variants from 22 ± 6to to serve an endogamous, uninsured, agrarian community. 5 ± 3 per proband. Nineteen (51%) alleles were de novo and 17 Methods: Seventy-nine probands (newborn to 49.8 years) who (46%) inherited; the latter added to a population-based diagnostic presented between 1998 and 2015 remained undiagnosed after panel. We found actionable secondary variants in 21 (4.2%) of 502 biochemical and molecular investigations. We generated WES data subjects, all of whom opted to be informed. for probands and family members and vetted variants through Conclusion: CMA and family-based WES streamline and rephenotyping, segregation analyses, and population studies. economize diagnosis of rare genetic disorders, accelerate novel Results: The most common presentation was neurological disease gene discovery, and create new opportunities for community-based (64%). Seven (9%) probands were diagnosed by CMA. -
Nprl3 Gene Intron That Enhances Its Transcription in Peripheral Blood
Scuola Internazionale Superiore di Studi Avanzati PhD Course in Functional and Structural Genomics Discovery of a human VNTR allelic variant in Nprl3 gene intron that enhances its transcription in peripheral blood Thesis submitted for the degree of “Philosophiæ Doctor” Candidate Supervisor Maria Bertuzzi Prof. Stefano Gustincich Academic Year 2014-2015 Table of contents Table of contents Abstract ....................................................................................................................................1 Introduction ..............................................................................................................................3 Gene expression regulation ..................................................................................................3 Gene expression profiling ................................................................................................5 NanoCAGE ......................................................................................................................6 TSS complexity ................................................................................................................7 Expression Quantitative Trait Loci (eQTL) .....................................................................8 Repetitive elements in the mammalian genome.................................................................10 Minisatellites and human diseases .................................................................................11 Parkinson’s disease.............................................................................................................14 -
NPRL3 (L-20): Sc-242062
SAN TA C RUZ BI OTEC HNOL OG Y, INC . NPRL3 (L-20): sc-242062 BACKGROUND PRODUCT NPRL3 (nitrogen permease regulator 3-like protein), also known as CGTHBA Each vial contains 200 µg IgG in 1.0 ml of PBS with < 0.1% sodium azide (conserved gene telomeric to α globin cluster), MARE, NPR3 or RMD11, is a and 0.1% gelatin. 569 amino acid protein that belongs to the NPR3 family. NPRL3 is widely ex- Blocking peptide available for competition studies, sc-242062 P, (100 µg pressed and forms a heterodimer with NPRL2. The gene that encodes NPRL3 peptide in 0.5 ml PBS containing < 0.1% sodium azide and 0.2% BSA). consists of approximately 54,587 bases and maps to human chromosome 16p13.3. Encoding over 900 genes and consisting of approximately 90 mil lion APPLICATIONS base pairs, chromosome 16 makes up nearly 3% of the human genome and is associated with a variety of genetic disorders. The GAN gene is located on NPRL3 (L-20) is recommended for detection of NPRL3 of mouse, rat and chromosome 16 and, when mutated, may lead to giant axonal neuropathy, a human origin by Western Blotting (starting dilution 1:200, dilution range nervous system disorder characterized by increasing malfunction with growth. 1:100-1:1000), immunofluorescence (starting dilution 1:50, dilution range Alterations in the CREB gene and NOD2 gene, both of which are located on 1:50-1:500) and solid phase ELISA (starting dilution 1:30, dilution range chromosome 16, results in Rubinstein-Taybi syndrome and Crohn’s disease, 1:30-1:3000). -
KICSTOR Recruits GATOR1 to the Lysosome and Is Necessary for Nutrients to Regulate Mtorc1
KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1 The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Wolfson, R. L., L. Chantranupong, G. A. Wyant, X. Gu, J. M. Orozco, K. Shen, K. J. Condon, et al. 2017. “KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1.” Nature 543 (7645): 438-442. doi:10.1038/nature21423. http:// dx.doi.org/10.1038/nature21423. Published Version doi:10.1038/nature21423 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:34375206 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nature. Manuscript Author Author manuscript; Manuscript Author available in PMC 2017 August 15. Published in final edited form as: Nature. 2017 March 16; 543(7645): 438–442. doi:10.1038/nature21423. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1 Rachel L. Wolfson1,2,3,4,*, Lynne Chantranupong1,2,3,4,*, Gregory A. Wyant1,2,3,4, Xin Gu1,2,3,4, Jose M. Orozco1,2,3,4, Kuang Shen1,2,3,4, Kendall J. Condon1,2,3,4, Sabrina Petri5, Jibril Kedir1,2,3,4, Sonia M. Scaria1,2,3,4, Monther Abu-Remaileh1,2,3,4, Wayne N. -
Documenting Orang-Utan Sleep Architecture: Sleeping Platform Complexity Increases Sleep Quality in Captive Pongo
Behaviour 150 (2013) 845–861 brill.com/beh Documenting orang-utan sleep architecture: sleeping platform complexity increases sleep quality in captive Pongo David R. Samson a,∗ and Robert W. Shumaker a,b,c a Department of Anthropology, Indiana University, Bloomington, IN 47405, USA b Indianapolis Zoo, 1200 W Washington Street, Indianapolis, IN 46222, USA c Krasnow Institute at George Mason University, 4400 University Dr Fairfax, VA 22030, USA *Corresponding author’s e-mail address: [email protected] Accepted 29 March 2013 Abstract Of the extant primates, only 20 non-human species have been studied by sleep scientists. Notable sampling gaps exist, including large-bodied hominoids such as gorillas (Gorilla gorilla), orang- utans (Pongo spp.) and bonobos (Pan paniscus), for which data have been characterized as high priority. Here, we report the sleep architecture of three female and two male orang-utans housed at the Indianapolis Zoo. Sleep states were identified by scoring correlated behavioural signatures (e.g., respiration, gross body movement, muscle atonia, random eye movement, etc.). The captive orang-utans were focal subjects for a total of 70 nights (1013 h) recorded. We found that orang- utans slept an average of 9.11 h (range 5.85–11.2 h) nightly and were characterized by an average NREM of 8.03 h (range 5.47–10.2 h) and REM of 1.11 (range: 0.38–2.2 h) per night. In addition, using a sleeping platform complexity index (SPCI) we found that individuals that manufactured and slept in more complex beds were characterized by higher quality sleep. Sleep fragmentation (the number of brief awakenings greater than 2 min per hour), arousability (number of motor activity bouts per hour), and total time awake per night were reduced by greater quality sleep environments. -
Hdl 124036.Pdf
Neurobiology of Disease 134 (2020) 104640 Contents lists available at ScienceDirect Neurobiology of Disease journal homepage: www.elsevier.com/locate/ynbdi Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy T Ruby E. Dawsona,c, Alvaro F. Nieto Guilb,c, Louise J. Robertsonb,c, Sandra G. Piltzb,c, ⁎ James N. Hughesa,c, Paul Q. Thomasb,c,d, a School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia b School of Medicine, University of Adelaide, Adelaide, SA 5005, Australia c Robinson Research Institute, University of Adelaide, Adelaide, SA 5005, Australia d Precision Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia ARTICLE INFO ABSTRACT Keywords: Mutations in the GAP activity toward RAGs 1 (GATOR1) complex genes (DEPDC5, NPRL2 and NPRL3) have been Neurodevelopment associated with focal epilepsy and focal cortical dysplasia (FCD). GATOR1 functions as an inhibitor of the Epilepsy mTORC1 signalling pathway, indicating that the downstream effects of mTORC1 deregulation underpin the Focal cortical dysplasia disease. However, the vast majority of putative disease-causing variants have not been functionally assessed for Molecular genetics mTORC1 repression activity. Here, we develop a novel in vitro functional assay that enables rapid assessment of Functional testing GATOR1-gene variants. Surprisingly, of the 17 variants tested, we show that only six showed significantly im- Developmental genetics CRISPR/CAS9 paired mTORC1 inhibition. To further investigate variant function in vivo, we generated a conditional Depdc5 Disease model mouse which modelled a ‘second-hit’ mechanism of disease. Generation of Depdc5 null ‘clones’ in the embryonic Mouse model brain resulted in mTORC1 hyperactivity and modelled epilepsy and FCD symptoms including large dysmorphic mTOR neurons, defective migration and lower seizure thresholds. -
Evolution of Hemoglobin and Its Genes
Downloaded from http://perspectivesinmedicine.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Evolution of Hemoglobin and Its Genes Ross C. Hardison Center for Comparative Genomics and Bioinformatics, Huck Institute of Genome Sciences, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, University Park, Pennsylvania 16802 Correspondence: [email protected] Insights into the evolution of hemoglobins and their genes are an abundant source of ideas regarding hemoglobin function and regulation of globin gene expression. This article pre- sents the multiple genes and gene families encoding human globins, summarizes major events in the evolution of the hemoglobin gene clusters, and discusses how these studies provide insights into regulation of globin genes. Although the genes in and around the a-like globin gene complex are relatively stable, the b-like globin gene clusters are more dynamic, showing evidence of transposition to a new locus and frequent lineage-specific expansions and deletions. The cis-regulatory modules controlling levels and timing of gene expression are a mix of conserved and lineage-specific DNA, perhaps reflecting evolutionary constraint on core regulatory functions shared broadly in mammals and adaptive fine-tuning in different orders of mammals. wide range of animals, vertebrate and inver- globin genes, and attempts to modulate globin Atebrate, use hemoglobins to transport oxy- gene expression are a fundamental approach to gen, carrying it from lungs, gills, or -
Government Accountability for Torture and Ill-Treatment in Health Settings
Government Accountability for Torture and Ill-Treatment in Health Settings AN OPEN SO CIETY FO UNDA TIO N S BRIEF ING PAPER HE ABSOLUTE prohibition under human health settings in their reports and make actionable rights law of all forms of torture and cruel, recommendations to governments on how to stop this abuse. inhuman, and degrading treatment (“torture and ill-treatment”) does not apply only to prisons, Tpretrial detention centers, and other places where torture The Legal Definition of Torture and ill-treatment are commonly thought to occur. It also and Ill-Treatment applies to places such as schools, hospitals, orphanages, and social care institutions—places where coercion, The legal definition of torture and ill-treatment is broad power dynamics, and practices occurring outside the enough to encompass a range of abuses occurring in purview of law or justice systems can contribute to the health settings. Under international law, any infliction infliction of unjustified and severe pain and suffering on of severe pain and suffering by a state actor or with state marginalized people. instigation, consent, or acquiescence can, depending on the circumstances, constitute either torture or ill-treatment.2 This briefing paper focuses on torture and ill-treatment in health settings, including hospitals, clinics, hospices, Whether an act qualifies as “torture,” “cruel and inhuman people’s homes, or anywhere health care is delivered. It treatment or punishment,” or “degrading treatment or does not seek to stigmatize health providers as “torturers,” punishment” depends on several factors, including the but rather to focus on government accountability for placing severity of pain or suffering inflicted, the type of pain and health providers and patients in unacceptable situations suffering inflicted (i.e.